Return to Article Details MiR-26a-5p exerts its influence by targeting EP300, a molecule known for its role in activating the PI3K/AKT/mTOR signaling pathway in CD8+tumor-infiltrating lymphocytes of colorectal cancer Download Download PDF
Themes by Openjournaltheme.com Themes by Openjournaltheme.com